Introduction
Suicidal behavior (SB) is a serious public health concern. More than 700,000 people die by suicide every year, representing one death every 40 s on average [1]. Factors contributing to increased risk of SBs are diverse and complex, but epidemiological studies indicate that the vast majority of attempted and completed suicides occur in people with mental disorders with mood disorders being the most frequently associated with SB [2, 3].
Understanding the pathophysiology of suicide is still a long-term goal. The evidence increasingly indicates a possible role of the immune-inflammatory response in the development and maintenance of depression and SB [4]. Inflammation has been associated with an increased risk of SBs above and beyond the risk associated with depression [5]. Neuroinflammatory processes are a pathophysiological mechanism that is essential for understanding SB in depressed patients. To explain the role of the immune system in the pathophysiology of suicide, a comprehensive model has been proposed. In this model, sleep disturbances, stress, childhood abuse, and infections induce dysregulation of the hypothalamic–pituitary–adrenal (HPA) axis that is associated with a chronic low-grade inflammatory state and increased risk of SBs [6]. It has therefore been suggested that inflammatory biomarkers are potentially useful in predicting and monitoring suicide risk in patients with depression [7].
Neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), and monocyte-to-lymphocyte ratio (MLR) indexes are convenient and cost-effective blood indicators of inflammatory status [8].
NLR is the most studied hematological parameter [9]. Neutrophils are the first defense cells of the innate immune system, representing an active nonspecific inflammatory mediator of phagocytosis and apoptosis functions [10], and lymphocytes represent the regulatory or protective component of the immune system [11–13]. NLR is the ratio between two different immune pathways reflecting the intensity of chronic stress. It may be more informative and perhaps less changed by unknown factors. PLR index is related to stress. The presence of stress activates the sympathetic nervous system, increases platelets, and induces endothelial permeability. When this permeability occurs, neutrophils and macrophages appear, generating peripheral inflammation [14]. Some studies suggest that PLR could be a better predictor than NLR for determining the severity of inflammation [15, 16]. An elevated level of MLR is associated with an overexpression of immunological genes that increases the production of cytokines related to monocytes and, as a consequence, activates microglia in the brain, causing neuroinflammation [14].
These indexes have been suggested as new indicators of low-grade inflammation and have been used as systemic inflammation prognostic scores in diseases such as cancer, coronary heart disease, and pancreatitis [17] and are also being investigated in neuropsychiatric disorders such as Alzheimer’s disease, schizophrenia, bipolar disorder, and major depressive disorder (MDD) [11, 18]. Recently, a meta-analysis [18] reported that inflammatory activation occurs in mood disorders and that NLR and PLR may be useful to detect this activation. NLR has been found to increase in depressed patients compared with healthy controls (HCs) [15, 19] and in depressed patients with SB. Moreover, studies have suggested that NLR may be a significant predictor of SB in MDD [4, 20] and could be more elevated in patients with recent suicide attempt (SA) [21]. In parallel, increased PLR levels have also been associated with the diagnosis and severity of depression [15, 22]. Finally, MLR was significantly higher in adolescents with SA than in HC [23].
However, potential mechanisms underlying inflammatory processes in depression and SB have yet to be fully elucidated. Biomarkers would provide more personalized methods for their assessment and treatment and would help to enhance our understanding of suicidal pathophysiology and improve prevention [24]. No previous reviews have examined NLR, PLR, and MLR in depressed patients with/without SA and suicidal ideation (SI) and HC. Therefore, we aimed to explore if there are significant differences in NLR, PLR, and MLR in (i) depressed patients with or without a lifetime history of SA; (ii) depressed patients with a lifetime history of SA vs HCs; and (iii) depressed patients with SI before and after treatment.
Materials and Methods
A systematic literature search was conducted according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) Statement [25]. The protocol was registered with the International Prospective Register of Systematic Reviews (PROSPERO) (CRD42022361238).
Search criteria
We systematically searched PubMed, Web of Science, and Scopus databases in September 2022. A single search strategy has been used for each of the databases:
Studies of neutrophil-to-lymphocyte ratio were systematically searched using the terms “(NLR OR neutrophil-to-lymphocyte ratio OR neutrophil-to-lymphocyte index OR neutrophil-to-lymphocyte rate OR neutrophil to lymphocyte ratio OR neutrophil to lymphocyte index OR neutrophil to lymphocyte rate OR neutrophil–lymphocyte ratio OR neutrophil lymphocyte index OR neutrophil lymphocyte rate OR neutrophil/lymphocyte ratio OR neutrophil/lymphocyte index OR neutrophil/lymphocyte rate) AND (depressive disorder OR depressive disorders OR depression OR mood disorder OR mood disorders OR major depression) AND (suicide OR suicidal behavior OR suicide attempt OR suicidal thoughts OR self-mutilation).”
In the same way, studies of platelet-to-lymphocyte ratio were systematically searched using the terms “(PLR OR platelet-to-lymphocyte ratio OR platelet-to-lymphocyte index OR platelet-to-lymphocyte rate OR platelet to lymphocyte ratio OR platelet to lymphocyte index OR platelet to lymphocyte rate OR platelet lymphocyte ratio OR platelet lymphocyte index OR platelet lymphocyte rate OR platelet/lymphocyte ratio OR platelet/lymphocyte index OR platelet/lymphocyte rate) AND (depressive disorder OR depressive disorders OR depression OR mood disorder OR mood disorders OR major depression) AND (suicide OR suicidal behavior OR suicidal attempt OR suicidal thoughts OR self-mutilation).”
Finally, studies of monocyte-to-lymphocyte ratio were systematically searched using the terms “(MLR OR monocyte-to-lymphocyte ratio OR monocyte-to-lymphocyte index OR monocyte-to-lymphocyte rate OR monocyte to lymphocyte ratio OR monocyte to lymphocyte index OR monocyte to lymphocyte rate OR monocyte lymphocyte ratio OR monocyte lymphocyte index OR monocyte lymphocyte rate OR monocyte/lymphocyte ratio OR monocyte/lymphocyte index OR monocyte/lymphocyte rate) AND (depressive disorder OR depressive disorders OR depression OR mood disorder OR mood disorders OR major depression) AND (suicide OR suicidal behavior OR suicidal attempt OR suicidal thoughts OR self-mutilation).”
We reviewed titles and abstracts to select potentially relevant papers. After this screening process, we reviewed the full texts and checked the references in the included studies, meta-analyses, and systematic reviews to identify additional studies. Some data were extracted from previous meta-analyses and systematic reviews.
Eligibility criteria
Case–control studies and cross-sectional data from longitudinal studies that compared NLR, PLR, and/or MLR indexes among depressed patients with SB, depressed patients without SB, and HCs were included, based on the following criteria: (i) patients with MDD according to standardized diagnostic criteria; (ii) measurement of NLR, PLR, and/or MLR in young people and adults; (iii) patients with current SI and history of SB. Only articles in English published in the last 5 years were included. Conference and meeting abstracts, meta-analyses, reviews, and pilot studies were excluded (see Supplementary Table S1).
Data extraction and assessment of methodological quality
Data were extracted by two independent authors (AV and PAS) and verified by the other two (JR and LJ). Extracted data included author, year of publication, country, diagnosis, study population, sample size, age, ratios of females, depression and suicide scales, type of outcome (SI/SA), and type and quality of the study. Results were ordered according to indexes (Table 1). The methodological quality of the included studies was assessed using the Oxford criteria [33]. Only medium- and high-quality papers were included in the final review. Any disagreements between reviewers were resolved by discussion and consensus.
Table 1. Main characteristics and results of articles included in the review.
| Author, date Country | Diagnosis | Total sample mean age (SD) sex (% females) | Suicidal behavior mean age (SD) sex (% females) | Control patients mean age (SD) sex (% females) | Healthy controls mean age (SD) sex (% females) | Depression and suicidal ideation scales | SI/SA group | Type and quality of study | Outcome |
|---|---|---|---|---|---|---|---|---|---|
| Amitai et al. [26] |
Mostly depression + anxiety | N = 91 |
N = 22 |
N = 69 | Not available | K-SADS-PL |
SA | Case–control |
NLR and PLR at baseline were higher in SA group than in nSA group |
| NLR and PLR correlate with SI | |||||||||
| NLR was a better predictor of SB than PLR | |||||||||
| After 8 weeks of fluoxetine treatment, NLR and PLR indexes were higher but not significantly | |||||||||
| Adhikari et al. [27] |
MDD | N = 50 |
Not available | Not available | Not available | MADRS |
SI | Longitudinal |
Baseline: males and females do not differ in any blood parameters, except for a higher total white blood cell count in males |
| After pharmacotherapy (12 weeks), in females only, neutrophils were increased, lymphocytes decreased and consequently, NLR was increased in response to antidepressant therapy |
|||||||||
| Ekinci and Ekinci, [20] |
MDD | N = 189 |
N = 37 |
N = 102 |
N = 50 |
HDRS | SA | Case–control |
NLR was higher in patients with SA than in nSA and HC subjects. NLR was a predictor of recent SA in MDD patients |
| PLR was not significant | |||||||||
| Velasco et al. [4] |
MDD | N = 538 |
N = 402 |
N = 136 |
Not available | HDRS | SA | Cross-sectional |
NLR was higher in MDD patients with SA vs MDD patients without SA. NLR was a biological marker of SB with a cut-off value of 1.30, 75% sensitivity, and 35% specificity |
| PLR was higher in MDD patients with SA vs MDD patients without SA | |||||||||
| MLR did not show any differences between MDD patients with or without a history of SA | |||||||||
| Demirkol et al. [8] |
MDD | N = 74 |
Not available | Not available | Not available |
HDRS |
SI | Longitudinal |
AD + BLT showed significant improvement over AD monotherapy |
| HDRS scores decreased significantly 1 day after treatment and continued for 2 weeks after | |||||||||
| SI decreased significantly after treatment | |||||||||
| Neutrophils were decreased, lymphocytes were increased and consequently, NLR was decreased significantly in all patients after treatment | |||||||||
| PLR index did not differ before or after treatment | |||||||||
| Grudet et al. [28] |
MDD | N = 102 |
N = 17 |
N = 31 |
N = 54 |
HDRS |
SI | Case–control |
NLR did not show differences between MDD vs HC or between MDD with SI vs without SI |
| Lower levels of vitamin D were more associated with a pro-inflammatory status in MDD patients than HC, especially in MDD patients with SI | |||||||||
| Puangsri and Ninla-Aesong, [9] |
MDD | N = 193 | N = 81 |
MDD nSI n = 56 |
N = 56 |
PHQ-9 |
SA |
Case- control |
NLR was significantly higher in all MDD patients vs HC |
| PLR was significantly higher in all MDD patients vs HC |
|||||||||
| MLR in MDD SA was significantly higher than HC and in MDD nSI |
|||||||||
| Martínez-Botía, Velasco and Rolle et al. [29] |
MDD | N = 172 |
N = 48 |
N = 31 |
N = 93 |
HDRS | SA | Case–control |
NLR was not statistically significant where found between groups |
| PLR was not statistically significant where found between groups | |||||||||
| MLR was more significantly decreased with SA than MDD nSA and HC | |||||||||
| Yagci and Avci [30] |
Mostly depression + anxiety | N = 91 |
N = 46 |
Not available | N = 45 |
BDI |
SA | Case–control |
NLR was higher in SA than in HC |
| Önen et al. [31] |
MDD | N = 148; |
N = 15 | N = 43 | N = 90 |
CDI | SB (not specified if SA or SI) | Case–control |
NLR did not show any differences between groups |
| PLR was higher in the MDD group than in HC. PLR was a biological marker of MDD in children and adolescents with a cut-off value of 112.5, 70% sensitivity, and 65% specificity | |||||||||
| Gundogdu Meydaneri and Meydaneri [32] |
MDD | N = 53 |
N = 27 |
N = 26 |
Not available | None | SA | Cross-sectional |
NLR tended to be higher in the SA group. However, this difference was not statically significant |
| PLR tended to be higher in the SA group. However, this difference was not statically significant |
Abbreviations: AD, antidepressant; BAI, beck anxiety inventory; BDI, beck depression inventory; BLT, bright light therapy; BSSI, beck scale for suicide ideation; CDI, children’s depression inventory; CDRS-R, children’s depression rating scale- revised; CRP, C-reactive protein; C-SSRS, Columbia-suicide severity rating scale; DASS-21, depression anxiety stress scale; HC, healthy control; HDRS, Hamilton depression rating scale; K-SADS-PL, kiddie-schedule for affective disorders & schizophrenia – present and lifetime version; MADRS, Montgomery–Asberg depression rating scale; MDD, major depressive disorder; MLR, monocyte/lymphocyte ratio; NLR, neutrophil/lymphocyte ratio; nSA, non-suicide attempt; nSI, non-suicidal ideation; PHQ-9, patient health questionnaire; PLR, platelet/lymphocyte ratio; SA, suicide attempt; SB, suicidal behavior; SI, suicidal ideation; SD, standard deviation; SIS-MAP, scale for impact of suicidality management and assessment and planning of care; 8Q, 8 questionnaire (Thai-version of a suicidality module of Mini International Neuropsychiatric Interview).
Results
Study selection and characteristics
A total of 86 studies were identified from electronic databases and, after removing duplicates, there were 37 single records to be screened. After reading titles and abstracts, we identified 21 full-text articles to be assessed for eligibility but excluded 10 studies after the full text was read (the inclusion and exclusion process is depicted in Figure 1). Of those, 11 studies met the inclusion and quality criteria and were selected for this review.
Figure 1.
PRISMA 2020 flow diagram for new systematic reviews that included database searches.
[Figure omitted. See PDF]
A total of 10 papers were rejected for the following reasons: (i) type of article (review, letter, meeting abstract): two articles were meeting abstracts and two articles were letters to the editor; (ii) two articles did not include a study of SB, two articles did not specify depressed patients, and one study included parameters of peripheral inflammation other than NLR, PLR, and MLR; and (iii) one article was published in the Turkish language (see Supplementary Table S1).
All included studies were published between August 2017 and September 2022. Five studies were conducted in Turkey [8, 20, 30–32], one in India [27], two in Spain [4, 29], one in Sweden [28], one in Israel [26], and one in Thailand [9].
The 11 records included in the review yielded a total sample of 1,701 participants, of which 819 were patients with MDD and SB (including current SI and lifetime SA), 494 were control patients (MDD without SB), and 388 were HCs.
We included data from (i) six studies of NLR, PLR, and/or MLR in depressed patients with or without SB [4, 20, 26, 28, 29, 32]; (ii) six studies of NLR, PLR, and/or MLR in depressed patients with SB vs HC [9, 20, 28–31]; (iii) two studies of NLR in depressed patients with SI before (with or without monotherapy 4 weeks prior) and after pharmacotherapy (2 to 12 weeks after treatment), one of which also explored PLR [8, 27], respectively (Table 1).
Patients with major depressive disorder with or without suicidal behavior
In three studies with patients with moderate-to-severe depression, NLR was reported to be higher in suicide attempters compared with depressed patients without a history of SA [4, 20, 26]. NLR could be potentially used as a biomarker to predict recent and past SA [4]. However, these results were not confirmed in other studies. First, in two studies there was a (nonsignificant) tendency toward an increase in NLR in patients with a history of SA vs without any [29, 32]. One study examining the association between current SI and NLR in patients with MDD found no differences between patients with and without current SI in NLR [28] (Table 2).
Table 2. Neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and monocyte-to-lymphocyte ratio in major depressive disorder with suicidal behavior versus non-suicidal behavior patients.
| Author, date | Type of SB | MDD with SB | MDD without SB | |
|---|---|---|---|---|
| NLR | Mean (SD) | Mean (SD) | p-value | |
| Velasco et al. [4] | Recent SA |
2.37 (2.36) |
1.68 (0.80) | 0.001 |
| Amitai et al. [26] | SA | 2.16 (0.78) | 1.64 (0.96) | 0.019 |
| Ekinci and Ekinci [20] | Recent SA | 2.840 (0.162) | 1.858 (0.98) | 0.001 |
| Gundogdu Meydaneri and Meydaneri [32] | SA | 2.04 (0.89) | 1.85 (0.81) | 0.054 |
| Martínez-Botía et al. [29] | SA | 2.17 (1.66) | 1.68 (0.57) | 0.291 |
| Grudet et al. [28] | SI | 2.3 (1.0) | 2.2 (0.8) | 0.81 |
| PLR | Mean (SD) | Mean (SD) | p-value | |
|---|---|---|---|---|
| Velasco et al. [4] | Recent SA |
128.20 (61.65) |
109.97 (38.75) | 0.024 |
| Amitai et al. [26] | SA | 159.31 (53.98) | 133.56 (58.18) | 0.044 |
| Ekinci and Ekinci [20] | Recent SA | 141.4 (83.25) | 128.11 (48.76) | 0.248 |
| Gundogdu Meydaneri and Meydaneri [32] | SA | 120.81 (39.34) | 118.55 (42.39) | 0.73 |
| Martínez-Botía et al. [29] | SA | 122.39 (64.51) | 109.30 (28.50) | 0.416 |
| MLR | Mean (SD) | Mean (SD) | p-value | |
|---|---|---|---|---|
| Velasco et al. [4] | Recent SA |
0.28 (0.16) |
0.25 (0.10) | 0.573 |
| Martínez-Botía et al. [29] | SA | 0.26 (0.12) | 0.25 (0.08) | 0.851 |
Abbreviations: MDD, major depressive disorder; MLR, monocyte/lymphocyte ratio; NLR, neutrophil/lymphocyte ratio; PLR, platelet/lymphocyte ratio; SA, suicide attempt; SB, suicidal behavior; SI, suicidal ideation; SD, standard deviation.
Regarding the PLR index in patients with MDD, two studies reported PLR to be higher in patients with a history of SA vs those without any [4, 26]. Conversely, this difference was not observed in three other studies [20, 29, 32] (Table 2).
Finally, only two studies explored the MLR index in relation to SB in MDD, with no reported statistically significant differences between depressed patients with and without SB [4, 29] (Table 2).
Patients with major depressive disorder and suicidal behavior vs healthy controls
In three studies, NLR was reported to be higher in depressed patients with a history of SA vs HC [9, 20, 30]. However, three other studies reported no statistically significant differences [28, 29, 31] (Table 3).
Table 3. Neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and monocyte-to-lymphocyte ratio in major depressive disorder with suicidal behavior versus healthy controls.
| Author, date | MDD with SB | Healthy controls | |
|---|---|---|---|
| NLR | Mean (SD) | Mean (SD) | p-value |
| Ekinci and Ekinci [20] | 2.840 (0.162) | 1.81 (0.33) | 0.001 |
| Puangsri and Ninla-Aesong [9] | 2.01 (0.07) | 1.49 (0.04) | 0.001 |
| Yagci and Avci [30] | 2.77 (1.6) | 2.05 (0.59) | 0.009 |
| Martínez-Botía et al. [29] | 1.97 (1.35) | 1.87 (0.80) | 0.510 |
| Grudet et al. [28] | 2.3 (1.0) | 2.3 (1.2) | 0.81 |
| Önen et al. [31] | 1.94 (1.11) | 1.65 (0.66) | 0.780 |
| PLR | Mean (SD) | Mean (SD) | p-value |
|---|---|---|---|
| Puangsri and Ninla-Aesong [9] | 123.18 (3.35) | 105.80 (3.11) | 0.024 |
| Önen et al. [31] | 133.95 (41.65) | 114.44 (40.53) | 0.005 |
| Ekinci and Ekinci [20] | 141.4 (83.25) | 134.3 (61.4) | 0.248 |
| Martínez-Botía et al. [29] | 117.26 (53.49) | 117.99 (54.77) | 0.952 |
| MLR | Mean (SD) | Mean (SD) | p-value |
|---|---|---|---|
| Puangsri and Ninla-Aesong [9] | 0.21 (0.02) | 0.15 (0.01) | 0.027 |
| Martínez-Botía et al. [29] | 0.26 (0.11) | 0.30 (0.13) | 0.017 |
Abbreviations: MDD, major depressive disorder; MLR, monocyte/lymphocyte ratio; NLR, neutrophil/lymphocyte ratio; PLR, platelet/lymphocyte ratio; SA, suicide attempt; SB, suicidal behavior; SI, suicidal ideation; SD, standard deviation.
Regarding the PLR index, two studies reported that PLR was higher in depressed patients (including SA, SI, and nSI) vs HC [23, 30]. Conversely, in two studies, this difference was not observed [20, 29] (Table 3).
MLR was investigated in only two out of six studies, with inconsistent results. MLR was reported to be higher in depressed patients with SA vs HC [9]. However, MLR was reported to be decreased in depressed patients with SB vs HC [29] (Table 3).
Depressed patients with suicidal ideation before and after treatment for depression
There were two studies that evaluated NLR before and after antidepressant treatment. First, Demirkol et al. (2019) studied depressed patients (n = 74) with monotherapy 4 weeks before treatment and found a decrease in NLR during and after treatment with antidepressant therapy (AD) and bright light therapy (BLT), with a greater decrease compared with AD monotherapy [NLR mean (SD) = 2.31(1.05) pretreatment vs 2.25 (0.96) after treatment vs 1.9 (0.9) 2 weeks after treatment; p < 0.001]. In addition, HDRS scores and SI were also significantly decreased after treatment [HDRS mean (SD) = 20.69 (4.21) pretreatment vs 16.69 (5.96) after treatment vs 15.14 (5.33) 2 weeks after treatment; p < 0.001; and SI median (Q1–Q3): 5 [3–10] pretreatment vs 5 [1–9] after treatment vs 3.5 (0–7) 2 weeks after treatment; p < 0.001] [8]. However, in a sample of 50 depressed patients without antidepressant treatment the previous month, Adhikari et al. [27] found a significant increase in NLR after 12 weeks of antidepressant treatment only in females [NLR mean in females (SD) = 2.55 (0.87) pretreatment vs 2.85 (0.89) 12 weeks after treatment; p < 0.001].
Regarding PLR, only one study examined PLR levels in depressed patients with SI before and after treatment and concluded there was no significant change in PLR during AD treatment [PLR mean (SD) = 118.61 (39.01) pretreatment vs 118.16 (40.57) after treatment vs 117.96 (40.82) 2 weeks after treatment; p = 0.985] [8].
None of the studies included MLR.
Discussion
SB is a leading cause of death and disability worldwide [34]. Detecting and identifying potential biomarkers of peripheral inflammation in SB has the potential to provide the knowledge needed to understand the pathophysiology of SB, develop personalized therapies, and improve prevention. To date, this is the first review that has examined NLR, PLR, and MLR in depressed patients with and without SA and current SI versus HCs.
NLR, PLR, and MLR indexes emerge as relatively stable biomarkers of systemic inflammation [35], which, in turn, is cost-effective and easily accessible. Perhaps, for this reason, most of the studies included in this systematic review were conducted in low-income countries, which seem to be interested in this option given the potential value for clinical application.
According to our review, in depressed patients, NLR was higher in patients with a history of SA, suggesting that, if confirmed in larger studies, it could be a biomarker of suicidal vulnerability in these patients. Although this result was not observed in all studies, in the majority there was a tendency for increased NLR. To the best of our knowledge, only one study that examined the differences in patients with and without SI did not find this association [28]. However, it has been previously suggested that SA and SI are different phenomena with different explanations and predictors [36], and it seems that the relationship between the increase in NLR and suicidality occurs only in SA and not in SI [28]. In addition, NLR was higher in depressed patients with SA vs HC. However, these differences were not observed in depressed patients with SI vs HC. Mounting evidence indicates that activation of the immune-inflammatory response is linked to the development and maintenance of depression and SB [4, 7, 18].
Some studies suggest that PLR could be a better predictor than NLR for determining the severity of inflammation [15, 16]. Our review shows inconsistent results regarding PLR in patients with MDD (including SB). However, when compared with HC, the difference in the PLR index is observed more clearly in depressed patients. This phenomenon might be explained by the fact that platelets are one of the first cells to start an inflammatory cascade (cytokines, chemokines, the serotonin pathway), and patients with depression had a loss of equilibrium in hematopoietic production, resulting in an imbalance or distress in modulation [29].
The present review found no evidence for the link between MLR and SB in depressed patients, in contrast to some studies than showed MLR was higher in the manic episodes of bipolar disorder compared with euthymic states [37]. However, despite not being related to SB, high MLR in young people appears to be associated with self-harm when compared with young people without this behavior [14].
Finally, discrepant, and limited results were found regarding SI changes and inflammatory indexes following antidepressant treatment. These results may indicate that: (i) not all depressed patients show changes in the inflammatory response [27]; (ii) the mechanisms underlying the relationship between inflammation and suicide are still unclear [38]: and (iii) it has not been determined whether inflammation is a causative factor or a consequence of depression [11]. However, we also need to keep in mind that inflammatory response is influenced by multiple factors, such as body mass index, use of tobacco and other psychoactive substances, duration and severity of illness, resistance to antidepressant treatment, other psychiatric comorbidities, unbalanced diet, lack of exercise, and stress or traumatic life events in childhood or adulthood [27, 29, 39].
Limitations
First, our results are mostly based on cross-sectional studies, and a causal relationship between NLR and SI and SB in patients with MDD cannot be inferred. Second, other inflammatory parameters were not assessed in the review, precluding us from concluding whether increased NLR is an independent biomarker or is related to other immune and inflammatory changes in depressed patients. Third, the studies included in the systematic review are very heterogeneous (i.e., sample characteristics, small sample sizes, recruitment, and assessment of depression and suicidality), and therefore results remain preliminary and cannot be generalized to any specific population. Finally, due to the small number and small scale of studies included, we cannot exclude publication and reporting bias in those studies, possibly biasing the results of the systematic review.
Conclusion
In conclusion, the present review found preliminary evidence for an association between NLR and SB in patients with MDD. Our results reinforce the idea that neuroinflammatory processes may be important in the pathophysiology of SB in depressed patients. NLR could be an attractive, convenient, and cost-effective trait marker of suicidal vulnerability in patients with MDD. Future large-scale replication studies are needed to confirm the observed associations and to examine the apparently understudied role of PLR and MLR in depressed patients in greater depth.
Corresponding author: María Paz García-Portilla; Email: [email protected]
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
© The Author(s), 2023. Published by Cambridge University Press on behalf of European Psychiatric Association. This work is licensed under the Creative Commons Attribution License This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0), which permits unrestricted re-use, distribution and reproduction, provided the original article is properly cited. (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Abstract
Background
Inflammatory biomarkers are reportedly increased in depressed patients. Several studies have been conducted using neutrophil/lymphocyte ratio (NLR), platelet/lymphocyte ratio (PLR), and monocyte/lymphocyte ratio (MLR). The objective of this systematic review was to study the relationship between these peripheral biomarkers and suicidality in depressed patients with/without suicidal behavior, including suicide attempts and ideation, and healthy controls.
Methods
We searched the following relevant terms in the PubMed, Web of Science, and Scopus databases published in the last 5 years. We assessed the methodological quality of included studies using the Oxford criteria and reviewed the evidence following PRISMA guidelines.
Results
Eleven studies were retained for the data synthesis, with a total sample of 1,701 participants, of which the majority (819) were patients with depression and suicidal behavior, 494 were depressed patients without suicidal behavior, and only 388 were healthy participants. Our results reinforce the idea that NLR could be an attractive, convenient, and cost-effective trait marker of suicidal vulnerability in patients with major depressive disorder (MDD).
Conclusion
Future large-scale replication studies are needed to examine the apparently understudied role of PLR and MLR in depressed patients in greater depth.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
; Lengvenyte, A 2
; Rodriguez-Revuelta, J 3 ; Jimenez-Treviño, L 3
; Courtet, P 4
; Garcia-Portilla, M P 5
; Bobes, J 1
; Sáiz, P A 5
1 Department of Psychiatry, University of Oviedo, Oviedo, Spain; Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Instituto de Salud Carlos III, Madrid, Spain; Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), Oviedo, Spain; Instituto de Neurociencias del Principado de Asturias (INEUROPA), Oviedo, Spain
2 Department of Emergency Psychiatry and Acute Care, CHU de Montpellier, Montpellier, France; IGF, University of Montpellier, CNRS, INSERM, Montpellier, France; Psychiatric Clinic, Institute of Clinical Medicine, Faculty of Medicine, Vilnius University, Vilnius, Lithuania
3 Department of Psychiatry, University of Oviedo, Oviedo, Spain; Instituto de Neurociencias del Principado de Asturias (INEUROPA), Oviedo, Spain; Mental Health Services of the Principality of Asturias (SESPA), Oviedo, Spain
4 Department of Emergency Psychiatry and Acute Care, CHU de Montpellier, Montpellier, France; IGF, University of Montpellier, CNRS, INSERM, Montpellier, France
5 Department of Psychiatry, University of Oviedo, Oviedo, Spain; Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Instituto de Salud Carlos III, Madrid, Spain; Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), Oviedo, Spain; Instituto de Neurociencias del Principado de Asturias (INEUROPA), Oviedo, Spain; Mental Health Services of the Principality of Asturias (SESPA), Oviedo, Spain